BioLineRx Ltd. EV - Enterprise Value 2011-2026 | BLRX

Annual EV - Enterprise Value BioLineRx Ltd.

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
15 M	46.4 M	15 M	1.35 B	50.9 M	36.9 M	59.3 M	101 M	60.4 M	51.1 M	62.8 M	73.9 M	86.4 M	53.9 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.35 B	15 M	148 M

EV - Enterprise Value of other stocks in the Biotechnology industry

Issuer	EV - Enterprise Value	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	1.82 B	-	2.43 %	$ 254 M	Germany
AgeX Therapeutics AGE	6.28 M	-	-10.17 %	$ 12.2 K	USA
Autolus Therapeutics plc AUTL	1.11 B	$ 1.37	-8.67 %	$ 350 M	Britain
Aeglea BioTherapeutics AGLE	725 M	-	-	$ 1.01 B	USA
Adagene ADAG	395 M	$ 1.65	6.11 %	$ 92.9 M	China
Alterity Therapeutics Limited ATHE	-28.9 M	$ 3.43	-2.69 %	$ 8.25 B	Australia
Biogen BIIB	28.3 B	$ 177.93	-4.15 %	$ 25.9 B	USA
Arrowhead Pharmaceuticals ARWR	6.02 B	$ 65.89	-0.06 %	$ 8.81 B	USA
Alexion Pharmaceuticals, Inc. ALXN	1.95 B	-	-	$ 40.3 B	USA
Biophytis SA BPTS	525 M	-	-13.47 %	$ 169 M	France
Akero Therapeutics AKRO	2.99 B	-	-	$ 3.67 B	USA
AVROBIO AVRO	-35.4 M	-	1083.1 %	$ 745 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	3.41 B	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	4.79 M	-	-18.52 %	$ 27.3 M	Britain
AstraZeneca PLC AZN	57.7 B	$ 94.4	0.82 %	$ 96.9 B	Britain
BeiGene, Ltd. BGNE	253 B	-	0.49 %	$ 251 B	Cayman-islands
Bellicum Pharmaceuticals BLCM	-9.74 M	-	-9.72 %	$ 5.89 M	USA
Berkeley Lights BLI	115 M	-	-7.31 %	$ 87 M	USA
Институт стволовых клеток человека ISKJ	14.1 M	-	-	-	Russia
Ascendis Pharma A/S ASND	726 M	$ 214.55	2.77 %	$ 5 B	Danmark
Codiak BioSciences CDAK	281 M	-	-55.98 %	$ 2.15 M	USA
ARCA biopharma ABIO	436 M	-	1052.0 %	$ 415 M	USA
Bristol-Myers Squibb Company BMY	180 B	$ 55.84	0.13 %	$ 113 B	USA
Cerevel Therapeutics Holdings CERE	6.84 B	-	-	$ 7.29 B	USA
Acasti Pharma ACST	24 M	-	4.01 %	$ 150 M	Canada
Caladrius Biosciences CLBS	-6.94 M	-	-16.75 %	$ 25.8 M	USA
Clearside Biomedical CLSD	122 M	-	-	$ 25.3 M	USA
Chimerix CMRX	95.8 M	-	-	$ 756 M	USA
Adaptimmune Therapeutics plc ADAP	2.15 B	-	-15.15 %	$ 60.3 M	Britain
BioNTech SE BNTX	-6.64 B	$ 106.88	4.6 %	$ 27.2 B	Germany
Can-Fite BioPharma Ltd. CANF	647 M	$ 4.18	-1.65 %	$ 9.1 B	Israel
AIkido Pharma AIKI	22.8 M	-	1.93 %	$ 17.4 M	USA
Catalyst Biosciences CBIO	38.1 M	$ 11.09	1.0 %	$ 730 M	USA
Albireo Pharma ALBO	417 M	-	-0.23 %	$ 916 M	USA
CureVac N.V. CVAC	3.19 B	-	-	$ 867 M	Germany
Acer Therapeutics ACER	38.2 M	-	2.71 %	$ 14 M	USA
Alpine Immune Sciences ALPN	363 M	-	-	$ 2.17 B	USA
AlloVir ALVR	-64.1 M	-	4.14 %	$ 49.1 M	USA
Ayala Pharmaceuticals AYLA	5.32 M	-	-	$ 7.46 M	Israel
Coherus BioSciences CHRS	929 M	$ 1.69	2.12 %	$ 159 M	USA
Ampio Pharmaceuticals AMPE	-1.05 M	-	-11.43 %	$ 502 K	USA
Amphastar Pharmaceuticals AMPH	2 B	$ 28.99	-1.39 %	$ 1.4 B	USA
Celldex Therapeutics CLDX	18.3 M	$ 25.71	0.16 %	$ 1.66 M	USA
CTI BioPharma Corp. CTIC	664 M	-	-	$ 1.2 B	USA
Cellectis S.A. CLLS	109 M	$ 4.24	-0.47 %	$ 116 M	France
Acorda Therapeutics ACOR	-13.2 M	-	-24.86 %	$ 820 K	USA
Applied Molecular Transport AMTI	7.6 M	-	-	$ 10.1 M	USA
Brickell Biotech BBI	515 K	-	-5.38 %	$ 6.06 M	USA
Burford Capital Limited BUR	3.22 B	$ 9.57	-0.78 %	$ 1.55 B	Britain